Jason Roszik

54PUBLICATIONS
326CO-AUTHORS
Molecular targetsPredictive and prognostic markersReaction engineering (excl. nuclear reactions)Genomics and transcriptomicsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

|Oct 11, 2024
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.

Chandrani Chattopadhyay, Janos Roszik, Rajat Bhattacharya

|Jun 20, 2024
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.

Sunil Acharya, Rafet Basar, May Daher

|May 25, 2024
A Gold Standard-Derived Modular Barcoding Approach to Cancer Transcriptomics.

Yan Zhu, Mohamad Karim I Koleilat, Jason Roszik

|Feb 09, 2024
Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.

Jonathan Goldberg, Na Qiao, Jennifer L Guerriero

|Dec 21, 2023
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.

Vivek Subbiah, Niamh Coleman, Sarina A Piha-Paul

Pageof 9

Frequent Collaborators

14 joint publications

Vivek Subbiah

7 joint publications

David S Hong

6 joint publications

John A Livingston

6 joint publications

Alexander Lazar